> It's not for free, though low enough to where no biotech company would make a profit on new therapies at the current R&D spend if the US paid the same rates t

> It's not for free, though low enough to where no biotech company would make a profit on new therapies at the current R&D spend if the US paid the same rates that everyone else is paying today. Where are all the anti-taxes people on this apparent involuntary charity for the pharmaceutical industry?